Acrivon Therapeutics Inc.... (ACRV)
undefined
undefined%
At close: undefined
7.06
-0.28%
After-hours Dec 13, 2024, 04:00 PM EST

Acrivon Therapeutics Inc. Common Stock Forcast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for ACRV stock have an median target of 22, with a low estimate of 16 and a high estimate of 30. The median target predicts an increase of 210.73% from the current stock price of 7.08.

Analyst Consensus: Buy
Target Low Average Median High
Price $16 $22.4 $22 $30
Change 125.99% 216.38% 210.73% 323.73%

AI Analyst Report

BMO Capital maintains an Outperform rating on Acri... Unlock content with Pro Subscription

Updated Nov 14, 2024

Rating Mar 24Apr 24May 24Aug 24Sep 24Nov 24
Strong Buy 001000
Buy 171142
Hold 010000
Sell 000000
Strong Sell 000000
Total 1 8 2 1 4 2

Financial Forecast this Year

Revenue This Year
n/a
Revenue Next Year
809.20K
from 0
Increased by -%
EPS This Year
-2.43
from -2.74
Increased by 11.3%
EPS Next Year
-2.7
from -2.43
Increased by -11.1%